Showing results (2351-2360 of 9,924) with videos related to

Sort By:
Pageof 993
Bone Marrow Transplantation|February 14, 2023
Effects of donor-specific antibodies on engraftment and long-term survival after allogeneic hematopoietic stem cell transplantation-A systematic review and meta-analysisYarui Huang, Chengxin Luo, Guixian Wu, et al.
Bone Marrow Transplantation|March 25, 2023
Effects of post-transplant maintenance therapy with decitabine prophylaxis on the relapse for acute lymphoblastic leukemiaJixin Fan, Runqing Lu, Jingkui Zhu, et al.
Bone Marrow Transplantation|February 14, 2026
CAR T-cell therapy in patients with acute lymphoblastic leukemia: a systematic review and meta-analysisVictor Navarro, Gloria Iacoboni, Sergi Camarillas, et al.
Bone Marrow Transplantation|February 24, 2025
Tuberculosis after hematopoietic cell transplantation: retrospective study on behalf of the Infectious Diseases Working Party of the EBMTJoanna Drozd-Sokołowska, Gloria Tridello, Inge Verheggen, et al.
Bone Marrow Transplantation|February 24, 2025
A model for predicting day-100 stem cell transplant-related mortality in AL amyloidosisEli Muchtar, Angela Dispenzieri, Vaishali Sanchorawala, et al.
Bone Marrow Transplantation|February 12, 2025
Cytogenetic and molecular risk-driven conditioning intensity in acute myeloid leukemia patients undergoing stem cell transplantation with post-transplant cyclophosphamide: a study from the acute leukemia working party of the EBMTJaime Sanz, Myriam Labopin, Jurjen Versluis, et al.
Bone Marrow Transplantation|January 29, 2025
Relationship between age, conditioning intensity, and outcome after allografting in adults age ≥60 years with AMLPhuong T Vo, Brenda M Sandmaier, Megan Othus, et al.
Bone Marrow Transplantation|November 8, 2024
Mismatched unrelated donors allogeneic hematopoietic stem cell transplantation with antithymocyte globulin for hematological malignancies: a multicenter retrospective study in ChinaLin Li, Yi Chen, Ting Chen, et al.
Bone Marrow Transplantation|December 5, 2024
Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myelomaNora Grieb, Alexander Oeser, Maximilian Ferle, et al.
Bone Marrow Transplantation|December 3, 2024
Better pre-transplant treatment options for TP53-mutated MDS: cytoreductive or non-cytoreductive therapy?Bingqian Jiang, Tingting Yang, Yanmin Zhao, et al.
Pageof 993